|
John A. Keller joined Incyte as executive vice president and chief business officer in September 2003.
Prior to joining Incyte, Dr. Keller was vice president, business development in GlaxoSmithKline's Worldwide Business Development group. Previously, he was vice president and director in the Alliance and Technology group for SmithKline Beecham Research and Development.
Dr. Keller received his B.A. in biology from Johns Hopkins University, and his Ph.D. in microbiology from Rutgers University. | 